Bayer

Bayer says Nexavar-Tarceva trial unsuccessful

Bayer says Nexavar-Tarceva trial unsuccessful

Reuters

Biogen, Bayer Drugs Don’t Slow MS Progress, Study Finds

Biogen, Bayer Drugs Don’t Slow MS Progress, Study Finds

Bloomberg

Sanofi: Don't Ignore This Powerhouse

Sanofi: Don't Ignore This Powerhouse

Seeking Alpha

Bayer HealthCare to Present Data on Secondary Prophylaxis with Kogenate(R) FS -- antihemophilic factor (recombinant) on Bleeding Frequency in Adults and Adolescents with Severe Hemophilia A

Bayer HealthCare to Present Data on Secondary Prophylaxis with Kogenate(R) FS -- antihemophilic factor (recombinant) on Bleeding Frequency in Adults and Adolescents with Severe Hemophilia A

PharmaLive

Bayer, J&J's Xarelto gets FDA priority review

Bayer, J&J's Xarelto gets FDA priority review

Reuters

Bayer Initiates Phase II/III Trial of New Recombinant Factor VIII Compound for Treatment of Hemophilia A

Bayer Initiates Phase II/III Trial of New Recombinant Factor VIII Compound for Treatment of Hemophilia A

news.genom.es

Seven pharma companies partner with Gates Foundation to speed TB drug discovery

Seven pharma companies partner with Gates Foundation to speed TB drug discovery

Yahoo/Fly on the Wall

The Race To Cure Multiple Sclerosis

The Race To Cure Multiple Sclerosis

Seeking Alpha

Priority Review for Bayer/Onyx

Priority Review for Bayer/Onyx

Yahoo/Zacks

Top heart doctors fret over new blood thinners

Top heart doctors fret over new blood thinners

Reuters